There were no significant associations between sputum IL-6, sIL-6R and CCL3 levels with FEV1% predicted, exacerbation rate, 6MWT distance, SGRQ, mMRC and CAT in COPD patients (p > 0.05 for all analysis, data not shown). This evidence concerns the gene CCL3 and chronic obstructive pulmonary disease.